Evaluation of the Effects of a Mixture of Amino Acids (Amixea) on Lean Body Mass and Muscle Strengh of Patients With Unresectable Advanced Non-small Cell Lung Cancer
NCT02877966 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2016-09-20
Summary
The primary objectives of this study are to evaluate the effects of an amino acid mixture (Amixea) on the body composition as assessed by DXA, and on QMVC as assessed by strain gauge, in advanced NSCLC patients, compared to placebo, after 10 weeks of treatment.
Secondary objectives are to evaluate the activity of Amixea on the degree of protein synthesis, on the nutritional risk and status and quality of life in advanced NSCLC patients, compared to placebo, after 10 weeks of treatment. In a small subsample, body composition will be evaluated opportunistically from clinically available CT scans.
Adherence to, and patient satisfaction of treatment will be evaluated as exploratory objectives of this study. Finally, the overall safety and product tolerability will be evaluated.
Conditions
- Cancer Patients With Cachexia
Interventions
- DIETARY_SUPPLEMENT
-
Amixea
Amixea is a mixture of amino acids. It consists mainly of essential amino acids (EAA) that cannot be synthesized de novo by the organism, and therefore must be supplied in its diet.
- OTHER
-
Placebo
Sponsors & Collaborators
-
Helsinn Healthcare SA
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-10-31
- Primary Completion
- 2018-08-31
- Completion
- 2018-12-31
Countries
- Australia
Study Locations
More Related Trials
-
A Phase 1b/2 Study of AMG 655 in Combination With Paclitaxel and Carboplatin for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer
NCT00534027 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of Induction and Maintenance Treatment of Advanced Non-squamous Non-Small Cell Lung Cancer
NCT00789373 ·Status: COMPLETED ·Phase: PHASE3
-
Bronchial Artery Infusion of Gemcitabine in Treating Patients With Recurrent or Progressive Non-Small Cell Lung Cancer
NCT00619021 ·Status: TERMINATED ·Phase: PHASE1
-
A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung Cancer
NCT00190710 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to See How Well and How Safely Different Treatments Work in a Group of Participants With Non-Small Cell Lung Cancer (NSCLC)
NCT06624059 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer
NCT00191256 ·Status: COMPLETED ·Phase: PHASE2
-
Nano-crystalline Megestrol Acetate Combined With Standard Treatment Versus Standard Treatment for First-line Extensive-stage Small Cell Lung Cancer in the Cachexia Phase
NCT06961201 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Study of Carboplatin/Paclitaxel in Combination With ABT-869 in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
NCT00716534 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab in the First-Line Treatment of Participants With Squamous Lung Cancer
NCT01788566 ·Status: COMPLETED ·Phase: PHASE2
-
Individualized Chemotherapy Based on BRCA1 and RRM1 mRNA for Advanced Non-small Cell Lung Cancer (NSCLC)
NCT01424709 ·Status: UNKNOWN ·Phase: PHASE2
-
Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the Pleura
NCT00601848 ·Status: TERMINATED ·Phase: PHASE2
-
Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer
NCT00227565 ·Status: COMPLETED ·Phase: PHASE2
-
Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)
NCT04625647 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer
NCT00070486 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant Sugemalimab + Chemotherapy Followed by Adjuvant Sugemalimab for Patients With Resectable Stage II-IIIA Non-small-cell Lung Cancer Patients
NCT06987734 ·Status: RECRUITING ·Phase: PHASE2
-
Neoadjuvant MPDL3280A, Nab-paclitaxel and Carboplatin (MAC) in NSCLC
NCT02716038 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Non-cytotoxic Suramin as a Chemosensitizer in Non-small Cell Lung Cancer
NCT01038752 ·Status: TERMINATED ·Phase: PHASE2
-
Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer
NCT00520676 ·Status: COMPLETED ·Phase: PHASE3
-
A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung Cancer
NCT00190840 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Abraxane and Carboplatin to Treat Small Cell Lung Cancer
NCT00454324 ·Status: TERMINATED ·Phase: PHASE2
-
Nanocrystalline Megestrol Acetate for the Treatment of Anorexia-Cachexia Syndrome in Extensive-Stage Small Cell Lung Cancer: A Prospective, Open-Label, Single-Arm Phase II Clinical Study
NCT06909383 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Testing the Use of Targeted Treatment for RET Positive Advanced Non-small Cell Lung Cancer
NCT05364645 ·Status: WITHDRAWN ·Phase: PHASE2
-
Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer: AIM-HIGH (Adjuvant Intervention in Molecular High Risk Patients)
NCT01817192 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung Cancer
NCT00079235 ·Status: COMPLETED ·Phase: PHASE2
-
Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer
NCT00094094 ·Status: COMPLETED ·Phase: PHASE2